<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24173134</article-id><article-id pub-id-type="pmc">4106812</article-id><article-id pub-id-type="doi">10.5935/abc.20130213</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Experimental Cardiac Arrest Treatment with Adrenaline, Vasopressin, or
Placebo</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pal&#x000e1;cio</surname><given-names>Manoel &#x000c2;ngelo Gomes</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>de Paiva</surname><given-names>Edison Ferreira</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>de Azevedo</surname><given-names>Luciano Cesar Pontes</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Timerman</surname><given-names>Ari</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib></contrib-group><aff id="aff01"><label>1</label> Instituto Dante Pazzanese de Cardiologia, S&#x000e3;o Paulo, SP - Brazil</aff><aff id="aff02"><label>2</label> Hospital S&#x000ed;rio-Liban&#x000ea;s, S&#x000e3;o Paulo, SP - Brazil</aff><author-notes><corresp id="c01"><bold>Mailing Address: Manoel Pal&#x000e1;cio</bold>, Av. Dante Pazzanese 500, Ibirapuera,
Postal Code 04012-909, S&#x000e3;o Paulo - SP - Brasil. E-mail:
<email>manoelpalacio@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>12</month><year>2013</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>12</month><year>2013</year></pub-date><volume>101</volume><issue>6</issue><fpage>536</fpage><lpage>544</lpage><history><date date-type="received"><day>06</day><month>12</month><year>2012</year></date><date date-type="rev-recd"><day>27</day><month>5</month><year>2013</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2013</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>The effect of vasoconstrictors in prolonged cardiopulmonary resuscitation (CPR)
has not been fully clarified.</p></sec><sec><title>Objectives</title><p>To evaluate adrenaline and vasopressin pressure effect, and observe the return of
spontaneous circulation (ROSC).</p></sec><sec><title>Methods</title><p>A prospective, randomized, blinded, and placebo-controlled study. After seven
minutes of untreated ventricular fibrillation, pigs received two minutes cycles of
CPR. Defibrillation was attempted (4 J/kg) once at 9 minutes, and after every
cycle if a shockable rhythm was present, after what CPR was immediately resumed.
At 9 minutes and every five minutes intervals, 0.02 mg/kg (n = 12 pigs)
adrenaline, or 0.4 U/kg (n = 12) vasopressin, or 0.2 mL/kg (n = 8) 0.9% saline
solution was administered. CPR continued for 30 minutes or until the ROSC.</p></sec><sec><title>Results</title><p>Coronary perfusion pressure increased to about 20 mmHg in the three groups.
Following vasoconstrictors doses, pressure level reached 35 mmHg
<italic>versus</italic> 15 mmHg with placebo (p &#x0003c; 0.001). Vasopressin effect
remained at 15-20 mmHg after three doses versus zero with adrenaline or placebo.
ROSC rate differed (p = 0.031) among adrenaline (10/12), vasopressin (6/12), and
placebo (2/8). Time-to-ROSC did not differ (16 minutes), nor the number of doses
previously received (one or two). There was no difference between
vasoconstrictors, but against placebo, only adrenaline significantly increased the
ROSC rate (p = 0.019).</p></sec><sec><title>Conclusion</title><p>The vasoconstrictors initial pressure effect was equivalent and vasopressin
maintained a late effect at prolonged resuscitation. Nevertheless, when compared
with placebo, only adrenaline significantly increased the ROSC rate.</p></sec></abstract><kwd-group><kwd>Epinephrine</kwd><kwd>Arginine Vasopressin</kwd><kwd>Ventricular Fibrillation</kwd><kwd>Cardiopulmonary Resuscitation</kwd><kwd>Models</kwd><kwd>Animal</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title>Introduction</title><p>Epinephrine (adrenaline) was discovered over 100 years ago, and has been used in human
cardiopulmonary resuscitation (CPR) since 1922<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. Vasopressin is also centenary, but its use in resuscitation began
in the 1990s<sup><xref rid="r02" ref-type="bibr">2</xref></sup>. These drugs are
vasoconstrictors that enhance vital organs perfusion, increasing the chance for return
of spontaneous circulation (ROSC)<sup><xref rid="r03" ref-type="bibr">3</xref></sup>. It
has been observed in animals and humans an association between ROSC rate and coronary
perfusion pressure (CPP), which is the pressure gradient between the aorta and right
atrium during "diastolic phase" of chest decompression<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup>. In turn, CPP
has a positive correlation with myocardial blood flow measured by radioactive
microspheres<sup><xref rid="r06" ref-type="bibr">6</xref>-<xref rid="r08" ref-type="bibr">8</xref></sup>.</p><p>Adrenaline acts on alpha-2 receptors causing vasoconstriction, and on alpha-1 and
beta-adrenergic receptors causing unwanted effects, such as increased oxygen consumption
and increased energy depletion of the fibrillating myocardium, among others<sup><xref rid="r09" ref-type="bibr">9</xref></sup>. Vasopressin causes vasoconstriction when
acting on their own V1a receptors located in the vascular smooth muscle, increasing the
CPP without the adrenergic undesired effects<sup><xref rid="r09" ref-type="bibr">9</xref></sup>. Vasopressin vasoconstrictor effect remained equal under prolonged
acidosis, in the same conditions in which alpha-adrenergic effect decreased<sup><xref rid="r10" ref-type="bibr">10</xref></sup>. Knowledge on vasopressin and its
cardiac receptors has been growing in the recent decades<sup><xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup>.</p><p>During the development of a cardiac arrest animal model and resuscitation, we planned
this study aiming to evaluate the pressure effect of adrenaline, vasopressin, and the
CPR itself or placebo, in addition to observing the cardiac arrest short-term survival.
The model was designed in order to simulate an out-of-hospital cardiac arrest in an
adult patient with seven minutes downtime until the emergency team arrival. In this pig
model of cardiac arrest due to eletrically induced ventricular fibrillation, with
exception of the treatment dose regimen, CPR followed the current standards<sup><xref rid="r13" ref-type="bibr">13</xref></sup>.</p></sec><sec sec-type="methods"><title>Methods</title><p>A prospective, randomized, blinded, placebo-controlled study, approved by the ethics
committees in the use of animals for research, according to local law and in line with
international standards. Thirty-two animals were successfully prepared and subject
consecutively to the protocol, one per day and two per week.</p><sec><title>Preparation</title><p>Large White Landrace pigs were fasted overnight and had free access to water. After
intramuscular pre-anesthesia with 5 mg/kg ketamine hydrochloride, and 0.5 mg/kg
midazolam, 12.5 mg/kg thiopental was administered in a marginal ear vein. Keeping the
animal in supine position, an orotracheal intubation was performed, inserting a N&#x000b0;. 7
cuffed tube. Anesthesia was maintained by continuous intravenous infusion plus 2 mL
fentanyl and midazolam boluses, as required, along with pancuronium for muscle
paralysis. The animals were mechanically ventilated: positive pressure, 10 mL/kg
tidal volume, 40% fraction of inspired oxygen, 3-5 mmHg positive end expiratory
pressure, and respiratory rate adjusted to maintain 40-45 mmHg of expired
CO<sub>2</sub> (ETCO<sub>2</sub>).</p><p>Following trichotomy, adhesive gel electrodes were placed and electrocardiogram
monitoring. The right jugular vein was dissected, and by adaptation of the Seldinger
technique, a vascular 8.5 french (F) sheath introducer with hemostatic valve was
inserted, through which anesthesia started to be administered. Likewise, the left
jugular vein and the right femoral artery received 8.5 F and 6 F sheaths,
respectively. Through the left jugular vein, a balloon-tipped 7.5 F Swan-Ganz
catheter was advanced to the pulmonary artery. Through the femoral artery and with a
guide wire, a 6 F pigtail catheter was advanced to the aortic root. Catheters
positioning was guided by the pressure curves. Catheters were connected to pressure
transducers, which were previously calibrated with a mercury sphygmomanometer and
aligned at bed height.</p><p>We used the Swan-Ganz catheter atrial port to monitor right atrial pressure. The
pigtail catheter was used to monitor the aortic pressure. A 5 F pacemaker bipolar
cable was introduced through the right jugular vein into the right ventricle wall.
This position was confirmed when ventricular extra-systoles appear on the monitor.
The cable was removed immediately after the electrical induction of ventricular
fibrillation, which was obtained by contacting cable poles with a common 9 V battery
poles for two seconds.</p></sec><sec><title>Data collection</title><p>We used an intensive care unit general monitor and an ETCO<sub>2</sub> common monitor
during the experiment. Electrocardiogram, ETCO<sub>2</sub>, aortic pressure and right
atrial pressure were recorded, along with on-line calculated CPP. These parameters
were recorded at 250 samples per second, using a computerized system for biological
data collection (MP100 System, Biopac, Inc.). Pressures and electrocardiogram were
collected directly to the system through proper transducers and surface electrodes.
ETCO<sub>2</sub> was collected through the specific monitor analog output. The
system software enabled to perform the measurements later. Heart rate and mechanical
ventilation, as well as chest compression rate and manual ventilation with AMBU, were
measured over the aortic pressure curve cycles and ETCO<sub>2</sub>,
respectively.</p></sec><sec><title>Experimental protocol</title><p>The protocol can be seen schematically in <xref ref-type="fig" rid="f01">Figure
1</xref>.</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Protocol design of experimental cardiac arrest and cardiopulmonary
resuscitation (CPR).</p></caption><graphic xlink:href="abc-101-06-0536-g01"/></fig><p>About one hour after preparation, anesthesia was stopped, ventricular fibrillation
was induced and the mechanical ventilation was interrupted simultaneously. In order
to simulate an out-of-hospital cardiac arrest case with downtime until the emergency
team arrival, there was no intervention in the first seven minutes. At 7 minutes, the
manual chest compression begun (100 compressions per minute with approximately 5 cm
depth), and the manual ventilation with AMBU (10 ventilations per minute with 100%
O<sub>2</sub> at 10L/min flowing into the reservoir). The cardiac massage rate was
mantained at about 100 based on listening to appropriate music. After two minutes CPR
cycle, a defibrillator (4 J/kg, monophasic) was used once at 9 minutes, immediately
followed by another CPR cycle. From the first attempt on, the rhythm was always
checked at the end of each cycle, and the defibrillator was used in the same way, if
required. Cardiac massage was resumed immediately after each attempt or after each
asystole rhythm checking or pulseless electrical activity. At 9 minutes and every
five minutes of CPR, an intravenous dose was applied in bolus: 0.02 mg/kg (n = 12
pigs) adrenaline (Epinephrine 1 mg/mL, Crist&#x000e1;lia); or 0.4 U/kg (n = 12)
arginine-vasopressin (Encrise 20 U/mL, Biolab); or 0.2 mL/kg (n = 8) placebo,
composed of 0.9% saline solution. The vasoconstrictors dilution in 0.9% saline
solution made it possible for each dose to have equal volume of 0.2 mL/kg. Treatment
was previously randomized and the protocol participants were blinded regarding which
treatment was applied to each animal. The same participant always carried out the
cardiac massage in order to avoid interpersonal differences in the massages, although
current guidelines recommend switching people in this role. The animals received 5
mg/kg of amiodarone at 11 minutes and 2.5 mg/kg at 16 minutes, if persistent
ventricular fibrillation was observed. CPR continued to a maximum of 30 minutes or to
the ROSC, which was defined as a suitable heart rhythm and systolic blood pressure
higher than 50 mmHg for over 20 minutes. In this case, anesthetic infusion was
restarted and mechanical ventilation proceeded according to previous settings, and
animals were monitored for 120 minutes. In these two hours, if necessary, 500 mL of
0.9% saline solution was administered rapidly to raise mean arterial pressure above
70 mmHg. No other drug was administered during the entire protocol, with the heparin
small doses exception to maintain the catheters patency. At 2 hours following ROSC,
the euthanasia was induced by administering 10 mL intravenous bolus of 19.1%
potassium chloride.</p></sec><sec><title>Systematization of measurements</title><p>Measurements were performed after the last experience. The measurement was
systematized to occur at 20 seconds before the timepoints marked on the parameters
curves, as on the pauses for rhythm checking. To avoid measurement tendencies, the
randomization secret was revealed only at the end, after hundreds of measurements
performed, and after making the data spreadsheet. Each measurement corresponds to
seven seconds or about 10 chest compressions. Measurements were exported with seven
digits precision to the statistical program.</p></sec><sec><title>Statistical analysis</title><p>We used the Number Cruncher Statistical System (NCSS 2007) software package for the
statistical analysis. ROSC rate was compared using the chi-square and Fisher's exact
test. Adapting a survival curve (Kaplan-Meyer) of 120 minutes with all animals
potentially alive during CPR and deaths occurring at 37 minutes, the hazard ratio
(HR) of death (Cox-Mantel) was calculated at specific time. The mean &#x000b1; standard error
values of the parameters were compared with repeated measures ANOVA and Bonferroni
(with control). Tests were considered significant at p &#x0003c; 0.05 (two-tailed). The
p-value is presented with three digits and no approximation. The measurements are
presented with the appropriate precision and approximation for each parameter.</p></sec><sec><title>Research supports</title><p>This research was partialy supported by Capes and Post-Graduation Medical Program of
the Instituto Dante Pazzanese de Cardiologia (IDPC); Funda&#x000e7;&#x000e3;o Adib Jatene (IDPC); and
Hospital S&#x000ed;rio-Liban&#x000ea;s, Instituto de Ensino e Pesquisa (Medical Intensive Care
Laboratory and Anesthesiology in which the experiments took place).</p></sec></sec><sec sec-type="results"><title>Results</title><p>The animals received similar volumes of anesthetic drugs, about 50 mL of fentanyl and
midazolam, and 30 mL of pancuronium, in addition to 2,000 mL of 0.9% saline solution.
Baseline pre-cardiac arrest parameters were similar, as can be seen in <xref ref-type="table" rid="t01">Table 1</xref>.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Pre-cardiac arrest baseline parameters similarity among 32 pigs, according to
randomized and blinded treatment applied during cardiopulmonary resuscitation</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>PARAMETER</bold></th><th rowspan="1" colspan="1"><bold>ADRENALINE (12 PIGS)</bold></th><th rowspan="1" colspan="1"><bold>VASOPRESSIN (12)</bold></th><th rowspan="1" colspan="1"><bold>PLACEBO (8)</bold></th><th rowspan="1" colspan="1"><bold>p</bold></th></tr></thead><tbody><tr align="center"><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td rowspan="1" colspan="1">36 &#x000b1; 0.5</td><td rowspan="1" colspan="1">35 &#x000b1; 0.6</td><td rowspan="1" colspan="1">36 &#x000b1; 0.9</td><td rowspan="1" colspan="1">NS</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">Temperature (&#x000ba;C)</td><td rowspan="1" colspan="1">37,6 &#x000b1; 0.3</td><td rowspan="1" colspan="1">38,0 &#x000b1; 0.4</td><td rowspan="1" colspan="1">37,7 &#x000b1; 0.3</td><td rowspan="1" colspan="1">NS</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg)</td><td rowspan="1" colspan="1">41 &#x000b1; 0.5</td><td rowspan="1" colspan="1">42 &#x000b1; 0.6</td><td rowspan="1" colspan="1">42 &#x000b1; 0.7</td><td rowspan="1" colspan="1">NS</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">Respiratory rate (rpm)</td><td rowspan="1" colspan="1">24 &#x000b1; 1.1</td><td rowspan="1" colspan="1">23 &#x000b1; 1.2</td><td rowspan="1" colspan="1">21 &#x000b1; 0.5</td><td rowspan="1" colspan="1">NS</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">Heart rate (bpm)</td><td rowspan="1" colspan="1">139 &#x000b1; 7</td><td rowspan="1" colspan="1">127 &#x000b1; 8</td><td rowspan="1" colspan="1">141 &#x000b1; 9</td><td rowspan="1" colspan="1">NS</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">Aortic pressure (mmHg)</td><td rowspan="1" colspan="1">141 &#x000b1; 4</td><td rowspan="1" colspan="1">141 &#x000b1; 4</td><td rowspan="1" colspan="1">134 &#x000b1; 9</td><td rowspan="1" colspan="1">NS</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">R-Atrial pressure (mmHg)</td><td rowspan="1" colspan="1">5 &#x000b1; 0,4</td><td rowspan="1" colspan="1">5 &#x000b1; 0.6</td><td rowspan="1" colspan="1">5 &#x000b1; 0.7</td><td rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><fn><p>ETCO<sub>2</sub>: expired carbon dioxide; NS: not significant; mean &#x000b1; standard
error</p></fn></table-wrap-foot></table-wrap><sec><title>ROSC rate</title><p>ROSC was observed in 18 animals that survived without cardiac events up to 120
minutes, such as spontaneous ventricular fibrillation, for example. The ROSC rate
differed (p = 0.031) among groups: adrenaline (10/12), vasopressin (6/12), and
placebo (2/8). ROSC rate increased following adrenaline compared with placebo (p =
0.019), and it did not differ following vasopressin compared with placebo or
adrenaline, as can be seen in <xref ref-type="fig" rid="f02">Figure 2</xref>.</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Return of spontaneous circulation (ROSC) rate and survival curve adaptation of
pigs in ventricular fibrillation, potentially alive during resuscitation
efforts and with all deaths occurring at 37 minutes, according to randomized
and blinded treatment</p></caption><graphic xlink:href="abc-101-06-0536-g02"/></fig></sec><sec><title>Coronary perfusion pressure</title><p>After CPR starting, pressure increased equally in all groups up to 9 minutes when
vasoconstrictors were administered, and the pressure level raised even more, as can
be seen in <xref ref-type="fig" rid="f03">Figure 3</xref>.</p><fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Coronary perfusion pressure (CPP) mean &#x000b1; standard error, pre-cardiac arrest at
time zero, and during cardiopulmonary resuscitation (CPR) initiated at 7
minutes of ventricular fibrillation (VF), according to randomized and blinded
treatment applied (T) repeatedly. Asterisks indicate timepoints of pressure
increase with vasoconstrictors, wich remained significant with vasopressin. The
pigs count decreases until 14 animals that not resuscitated: adrenaline 2/12,
vasopressin 6/12, and placebo 6/8.</p></caption><graphic xlink:href="abc-101-06-0536-g03"/></fig><p>The first dose of vasoconstrictors significantly increased CPP compared with placebo,
and with no significant difference between adrenaline and vasopressin. Pressure level
remained above 30 mmHg up to 13 minutes, or until four minutes since first dose.
After 19 minutes, successive vasoconstrictors doses did not increase CPP. The
vasopressin effect remained close to 20 mmHg, but adrenaline effect ended at the
third dose, when the pressure level dropped to near zero. The CPR plus placebo effect
reached approximately 20 mmHg and lasted only few minutes.</p></sec><sec><title>Time, doses and return of circulation</title><p>The time (and standard error) from cardiac arrest to ROSC was similar among the three
groups: adrenaline, 15 minutes and 45 seconds (50 seconds); vasopressin, 18 minutes
and 12 seconds (152 seconds); placebo 14 minutes and 18 seconds (72 seconds). The 18
animals mean was 16 minutes and 24 seconds (59 seconds), and median was 15 minutes
and 28 seconds; minimum of 13 minutes and 6 seconds, maximum of 29 minutes and 4
seconds. Only one animal had time-to-ROSC extended to over 19 minutes.</p><p>Most animals received one or two doses of treatment untill achieving ROSC, and with
no difference among count of doses per group: adrenaline, 1.6 (0.2); vasopressin, 1.8
(0.5); and placebo, 1.5 (0.5). Fourteen animals received six doses and had no
ROSC.</p><p>The ROSC occurred up to eight minutes of CPR in 2/3 cases, corresponding to four
cycles of cardiac massage, or up to three defibrillation attempts. The animals that
achieved ROSC received successive shocks and no previous rhythm was observed other
than ventricular fibrillation. The cumulative ROSC rate can be observed in <xref ref-type="fig" rid="f04">Figure 4</xref>.</p><fig id="f04" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Return of spontaneous circulation (ROSC) rate accumulated until the last
resuscitated pig in each treatment group.</p></caption><graphic xlink:href="abc-101-06-0536-g04"/></fig></sec><sec><title>Other parameters monitored during CPR</title><p>As it can be seen in <xref ref-type="fig" rid="f05">Figure 5</xref>, other parameters
did not differ among treatment groups, except for the aortic pressure, which defined
the CPP, since atrial pressure remained close to 20 mmHg for all time.</p><fig id="f05" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Parameters: mean &#x000b1; stardard error of pressures, expired carbon dioxide (ETCO2),
and respiratory rate, pre-cardiac arrest at time zero, and during
cardiopulmonary resuscitation started at 7 minutes, according to randomized and
blinded treatment applied in pigs electrically induced to ventricular
fibrillation. Manual chest compression rate was similar (99.5 &#x000b1; 0.1). Following
vasoconstrictors treatment at 9 minutes, there was significant effect (compared
with placebo) on the aortic pressure only</p></caption><graphic xlink:href="abc-101-06-0536-g05"/></fig><p>The mean cardiac massage rate (and standard error) was 99.5 (0.1) compressions per
minute, and manual ventilation rate was 10.5 (0.1) ventilations per minute. As these
rates, ETCO<sub>2</sub> did not differ among groups, increasing during the first
massage cycle and then progressively decreasing.</p></sec><sec><title>Cardiac arrest nonsurvival hazard ratio</title><p>Compared with placebo, the cardiac arrest nonsurvival risk decreased with adrenaline
(HR = 0.22, 95% CI 0.05 - 0.91, p = 0.043), and it did not differ with vasopressin
(HR = 0.67, 95% CI 0.21 - 2.12). Adrenaline significantly reduced the risk by 78%,
and vasopressin reduced by 33%, but with no statistical significance. Between these
vasoconstrictors there was no difference about short-term survival.</p></sec><sec><title>Post-cardiac arrest parameters</title><p>Up to two hours after achieving ROSC, the animals showed no statistical significant
difference in physiological parameters among treatment groups, as can be seen in
<xref ref-type="table" rid="t02">Table 2</xref>.</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2 </label><caption><p>Pre (baseline) and post-cardiac arrest parameters similarity among 18 pigs
treated with adrenaline (10 animals), vasopressin (6), or placebo (2)</p></caption><table frame="hsides" rules="rows"><thead><tr><th colspan="3" align="left" style="border-bottom:hidden" rowspan="1"><bold>PARAMETER</bold></th><th colspan="6" rowspan="1"><bold>POST-CARDIAC ARREST TIME</bold></th></tr></thead><tbody><tr align="center"><td rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Treatment</td><td rowspan="1" colspan="1">Baseline</td><td rowspan="1" colspan="1">10 min</td><td rowspan="1" colspan="1">20 min</td><td rowspan="1" colspan="1">30 min</td><td rowspan="1" colspan="1">60 min</td><td rowspan="1" colspan="1">90 min</td><td rowspan="1" colspan="1">120 min</td></tr><tr align="center"><td colspan="2" align="left" rowspan="1"><bold>Temperature (&#x000ba;C)</bold></td><td colspan="7" rowspan="1">&#x000a0;</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Adrenaline</td><td rowspan="1" colspan="1">37.5 &#x000b1; 0.4</td><td rowspan="1" colspan="1">37.9 &#x000b1; 0.4</td><td rowspan="1" colspan="1">38.1 &#x000b1; 0.4</td><td rowspan="1" colspan="1">38.3 &#x000b1; 0.4</td><td rowspan="1" colspan="1">38.6 &#x000b1; 0.4</td><td rowspan="1" colspan="1">38.8 &#x000b1; 0,4</td><td rowspan="1" colspan="1">38.9 &#x000b1; 0.4</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasopressin</td><td rowspan="1" colspan="1">38.7 &#x000b1; 0.3</td><td rowspan="1" colspan="1">39.1 &#x000b1; 0.3</td><td rowspan="1" colspan="1">39.2 &#x000b1; 0.3</td><td rowspan="1" colspan="1">39.4 &#x000b1; 0.3</td><td rowspan="1" colspan="1">39.6 &#x000b1; 0.2</td><td rowspan="1" colspan="1">39.8 &#x000b1; 0,2</td><td rowspan="1" colspan="1">39.9 &#x000b1; 0.3</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">38.4 &#x000b1; 0.5</td><td rowspan="1" colspan="1">38.1 &#x000b1; 1.2</td><td rowspan="1" colspan="1">38.5 &#x000b1; 0.9</td><td rowspan="1" colspan="1">38.9 &#x000b1; 1.0</td><td rowspan="1" colspan="1">39.1 &#x000b1; 1.2</td><td rowspan="1" colspan="1">39.3 &#x000b1; 1,1</td><td rowspan="1" colspan="1">39.4 &#x000b1; 1.2</td></tr><tr align="left"><td colspan="9" rowspan="1"><bold>ETCO<sub>2</sub> (mmHg)</bold></td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Adrenaline</td><td rowspan="1" colspan="1">42 &#x000b1; 1</td><td rowspan="1" colspan="1">41 &#x000b1; 1</td><td rowspan="1" colspan="1">42 &#x000b1; 1</td><td rowspan="1" colspan="1">42 &#x000b1; 1</td><td rowspan="1" colspan="1">43 &#x000b1; 1</td><td rowspan="1" colspan="1">43 &#x000b1; 1</td><td rowspan="1" colspan="1">43 &#x000b1; 1</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasopressin</td><td rowspan="1" colspan="1">43 &#x000b1; 1</td><td rowspan="1" colspan="1">35 &#x000b1; 3</td><td rowspan="1" colspan="1">37 &#x000b1; 3</td><td rowspan="1" colspan="1">41 &#x000b1; 2</td><td rowspan="1" colspan="1">44 &#x000b1; 1</td><td rowspan="1" colspan="1">45 &#x000b1; 1</td><td rowspan="1" colspan="1">42 &#x000b1; 1</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">41 &#x000b1; 2</td><td rowspan="1" colspan="1">39 &#x000b1; 1</td><td rowspan="1" colspan="1">41 &#x000b1; 4</td><td rowspan="1" colspan="1">37 &#x000b1; 5</td><td rowspan="1" colspan="1">44 &#x000b1; 2</td><td rowspan="1" colspan="1">41 &#x000b1; 3</td><td rowspan="1" colspan="1">40 &#x000b1; 1</td></tr><tr align="center"><td colspan="2" align="left" rowspan="1"><bold>Respiratory rate (rpm)</bold></td><td colspan="7" rowspan="1">&#x000a0;</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Adrenaline</td><td rowspan="1" colspan="1">24 &#x000b1; 1</td><td rowspan="1" colspan="1">23 &#x000b1; 1</td><td rowspan="1" colspan="1">23 &#x000b1; 1</td><td rowspan="1" colspan="1">23 &#x000b1; 1</td><td rowspan="1" colspan="1">23 &#x000b1; 1</td><td rowspan="1" colspan="1">24 &#x000b1; 1</td><td rowspan="1" colspan="1">24 &#x000b1; 1</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasopressin</td><td rowspan="1" colspan="1">25 &#x000b1; 2</td><td rowspan="1" colspan="1">25 &#x000b1; 2</td><td rowspan="1" colspan="1">25 &#x000b1; 2</td><td rowspan="1" colspan="1">25 &#x000b1; 2</td><td rowspan="1" colspan="1">24 &#x000b1; 2</td><td rowspan="1" colspan="1">24 &#x000b1; 2</td><td rowspan="1" colspan="1">26 &#x000b1; 2</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">21 &#x000b1; 1</td><td rowspan="1" colspan="1">21 &#x000b1; 1</td><td rowspan="1" colspan="1">21 &#x000b1; 1</td><td rowspan="1" colspan="1">21 &#x000b1; 1</td><td rowspan="1" colspan="1">19 &#x000b1; 3</td><td rowspan="1" colspan="1">21 &#x000b1; 3</td><td rowspan="1" colspan="1">21 &#x000b1; 3</td></tr><tr align="left"><td colspan="9" rowspan="1"><bold>Heart rate (bpm)</bold></td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Adrenaline</td><td rowspan="1" colspan="1">138 &#x000b1; 8</td><td rowspan="1" colspan="1">127 &#x000b1; 10</td><td rowspan="1" colspan="1">135 &#x000b1; 6</td><td rowspan="1" colspan="1">130 &#x000b1; 5</td><td rowspan="1" colspan="1">134 &#x000b1; 8</td><td rowspan="1" colspan="1">135 &#x000b1; 6</td><td rowspan="1" colspan="1">143 &#x000b1; 6</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasopressin</td><td rowspan="1" colspan="1">141 &#x000b1; 10</td><td rowspan="1" colspan="1">129 &#x000b1; 15</td><td rowspan="1" colspan="1">130 &#x000b1; 13</td><td rowspan="1" colspan="1">139 &#x000b1; 12</td><td rowspan="1" colspan="1">151 &#x000b1; 8</td><td rowspan="1" colspan="1">170 &#x000b1; 13</td><td rowspan="1" colspan="1">159 &#x000b1; 11</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">145 &#x000b1; 31</td><td rowspan="1" colspan="1">128 &#x000b1; 6</td><td rowspan="1" colspan="1">140 &#x000b1; 18</td><td rowspan="1" colspan="1">133 &#x000b1; 30</td><td rowspan="1" colspan="1">128 &#x000b1; 25</td><td rowspan="1" colspan="1">118 &#x000b1; 35</td><td rowspan="1" colspan="1">130 &#x000b1; 35</td></tr><tr align="left"><td colspan="9" rowspan="1"><bold>Aortic pressure (mmHg)</bold></td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Adrenaline</td><td rowspan="1" colspan="1">139 &#x000b1; 5</td><td rowspan="1" colspan="1">99 &#x000b1; 8</td><td rowspan="1" colspan="1">101 &#x000b1; 8</td><td rowspan="1" colspan="1">99 &#x000b1; 7</td><td rowspan="1" colspan="1">97 &#x000b1; 6</td><td rowspan="1" colspan="1">106 &#x000b1; 6</td><td rowspan="1" colspan="1">112 &#x000b1; 6</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasopressin</td><td rowspan="1" colspan="1">140 &#x000b1; 8</td><td rowspan="1" colspan="1">82 &#x000b1; 11</td><td rowspan="1" colspan="1">83 &#x000b1; 8</td><td rowspan="1" colspan="1">95 &#x000b1; 5</td><td rowspan="1" colspan="1">100 &#x000b1; 6</td><td rowspan="1" colspan="1">99 &#x000b1; 6</td><td rowspan="1" colspan="1">97 &#x000b1; 7</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">163 &#x000b1; 15</td><td rowspan="1" colspan="1">117 &#x000b1; 2</td><td rowspan="1" colspan="1">111 &#x000b1; 1</td><td rowspan="1" colspan="1">116 &#x000b1; 9</td><td rowspan="1" colspan="1">122 &#x000b1; 15</td><td rowspan="1" colspan="1">126 &#x000b1; 14</td><td rowspan="1" colspan="1">132 &#x000b1; 25</td></tr><tr align="center"><td colspan="2" align="left" rowspan="1"><bold>R-Atrial pressure (mmHg)</bold></td><td colspan="7" rowspan="1">&#x000a0;</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Adrenaline</td><td rowspan="1" colspan="1">4 &#x000b1; 1</td><td rowspan="1" colspan="1">9 &#x000b1; 1</td><td rowspan="1" colspan="1">9 &#x000b1; 1</td><td rowspan="1" colspan="1">8 &#x000b1; 1</td><td rowspan="1" colspan="1">7 &#x000b1; 1</td><td rowspan="1" colspan="1">6 &#x000b1; 1</td><td rowspan="1" colspan="1">6 &#x000b1; 1</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Vasopressin</td><td rowspan="1" colspan="1">4 &#x000b1; 1</td><td rowspan="1" colspan="1">10 &#x000b1; 1</td><td rowspan="1" colspan="1">9 &#x000b1; 1</td><td rowspan="1" colspan="1">9 &#x000b1; 1</td><td rowspan="1" colspan="1">8 &#x000b1; 1</td><td rowspan="1" colspan="1">7 &#x000b1; 1</td><td rowspan="1" colspan="1">7 &#x000b1; 1</td></tr><tr align="center"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">Placebo</td><td rowspan="1" colspan="1">3 &#x000b1; 1</td><td rowspan="1" colspan="1">9 &#x000b1; 1</td><td rowspan="1" colspan="1">9 &#x000b1; 1</td><td rowspan="1" colspan="1">7 &#x000b1; 1</td><td rowspan="1" colspan="1">6 &#x000b1; 1</td><td rowspan="1" colspan="1">5 &#x000b1; 1</td><td rowspan="1" colspan="1">4 &#x000b1; 1</td></tr></tbody></table><table-wrap-foot><fn><p>ETCO<sub>2</sub>: expired carbon dioxide; mean &#x000b1; standard error.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The results of this study were interesting about CPR itself consistent pressure effect,
and about initial equivalence of both vasoconstrictors. It was observed that CPR raised
pressure level to the threshold that favors ROSC chance, and two placebo-treated animals
survived for two hours. Vasoconstrictors increased pressure level even more, and the
risk of cardiac arrest nonsurvival decreased with both treatments, significantly with
adrenaline. It was observed also that adrenaline has lost its pressure effect after the
third dose; vasopressin maintained a significant pressure effect during 30 minutes of
CPR; and placebo, <italic>i.e</italic>., CPR itself maintained a pressure effect during
few minutes. In other studies, pressure effects similar to these have been
observed<sup><xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r18" ref-type="bibr">18</xref></sup>. It is important to highlight that blood concentration
of endogenous epinephrine and vasopressin increases during CPR<sup><xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup>.</p><p>In the current study, even with initial equivalent vasoconstrictors pressure effect, and
even with all similar parameters, only adrenaline significantly increased ROSC rate, and
so, it deserves some considerations.</p><sec><title>About this resuscitation study model</title><p>Swine species was chosen due to it human similarities, like anatomical,
physiological, cardiovascular, and mechanical of the chest wall during massage, in
spite of the natural species antidiuretic hormone be lysine instead of
arginine-vasopressin<sup><xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref></sup>. During the conception of this local
study model of resuscitation, it seemed appropriate to evaluate each vasoconstrictor
separately because there were several vasopressin half-life related uncertainties,
mainly during CPR. Reference literature quotes half-lifes as from four to 24.1
minutes<sup><xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr"> 24</xref></sup>. During CPR, lack of in human knowledge on
repeated-doses-vasopressin pharmacokinetics led to stablished one-dose only
use<sup><xref rid="r25" ref-type="bibr">25</xref></sup>.</p></sec><sec><title>Dose regimen</title><p>It was observed equivalent pressure effect between the two initial doses of
epinephrine and vasopressin (<xref ref-type="fig" rid="f03">Figures 3</xref> and
<xref ref-type="fig" rid="f05">5</xref>), but only vasopressin kept effect of
about 20 mmHg up to the end of CPR. Repeated doses, considering the prolonged
vasopressin half-life, did not cause a cumulative effect of CPP increasing, but
maintained stable pressure level for 30 minutes. However, with the same adrenaline
dose regimen, CPP level dropped to placebo similar level, despite repeated doses. In
other CPR studies, it was also observed a brief adrenaline effect and a sustained
vasopressin effect<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref></sup>.</p></sec><sec><title>Cardiac arrest time is critical</title><p>The ROSC rate can be influenced by several factors, especially by the circulatory
arrest time <italic>(no flow)</italic> and CPR time <italic>(low
flow</italic>)<sup><xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r29" ref-type="bibr">29</xref></sup>. In this study, attention was given
to every protocol timepoint, so that there would not be any groups difference, but is
not possible to control time-to-ROSC. To check whether there was influence of
treatment on time-to-ROSC, this time was precisely measured, and no groups difference
was observed. Therefore, the adrenaline ROSC rate advantage was not due to
differences in duration of ischemia.</p></sec><sec><title>Perfusion pressure and return of circulation</title><p>The duration of ischemia was similar, but the intensity may have been different. In
the microcirculation, local differences in specific receptor density and stimulation
intensity may explain the difference in the ROSC rate, since similar values of
perfusion pressure can coexist with different myocardial blood flows, depending on
the vasoconstrictor and on the dose<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup>. Despite
initial equivalent pressure effect and overall parameters similarity, it was observed
an improve in short-term survival with adrenaline <italic>versus</italic> placebo,
and it did not differ with vasopressin <italic>versus</italic> placebo. Between
vasopressin and adrenaline, there was no significant difference in ROSC rate and
short-term survival.</p></sec><sec><title>This animal model and two clinical studies</title><p>Recently, Jacobs et al. compared adrenaline (n = 272 patients) with placebo (n = 262)
in a randomized and double-blind clinical trial<sup><xref rid="r30" ref-type="bibr">30</xref></sup>. Survival to hospital discharge did not differ, but ROSC
chance (23.5% <italic>versus</italic> 8.4%) was higher with adrenaline <italic>(odds
ratio</italic> = 3.4, 95% CI 2.0 - 5.6). ROSC rates were smaller than it were in
this laboratory study. This can be due to initial rhythms and downtime until CPR,
which were unfavorable in clinical setting. These are important differences, so that
the vasoconstrictor observed result in clinical setting (23.5% of ROSC) did not even
exceed the placebo result in this laboratory study (25% of ROSC). In both studies, it
was observed that adrenaline significantly improved ROSC rate.</p><p>In another randomized study, adrenaline (n = 158) was compared with vasopressin (n =
178) in four doses of 0.045 mg/kg and 0.8 U/kg at every 5-10 minutes,
respectively<sup><xref rid="r31" ref-type="bibr">31</xref></sup>. The study did
not compare vasoconstrictor with placebo. As occurred in the laboratory,
vasoconstrictors ROSC rates did not differ (26.6% <italic>versus</italic> 28.7%).</p></sec><sec><title>Final considerations</title><p>This experimental study model has some limitations: animals are previously healthy,
but in clinical setting, there are usually other associated diseases; and duration of
ischemia is usually longer; this study was not designed to measure vital organs
perfusion or monitor cerebral perfusion pressure, much less the late survival or
neurologic function; a group with alternate or combined adrenaline and vasopressin
was not defined. Even so, the current study suggests that vasoconstrictors can be
more effectively used, and that further studies are required to better understand
this question.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In a pig model of cardiac arrest and 2010 standard cardiopulmonary resuscitation,
repeated doses of adrenaline or vasopressin were equivalent for initial blood pressure
increase. Adrenaline lost its effect at the third dose, unlike vasopressin that maintain
its pressure effect following each one of six doses. Without vasoconstrictors, manual
chest compression generated pressure for a few minutes. In spite of that, compared with
placebo treatment, the ROSC rate and cardiac arrest short-term survival were improved
with adrenaline, and it did not differ with vasopressin.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author contributions</bold></p><p>Conception and design of the research, analysis and interpretation of the data:
Pal&#x000e1;cio MAG, Paiva EF, Timerman A; acquisition of data: Pal&#x000e1;cio MAG, Paiva EF,
Azevedo LCP; statistical analysis and writing of the manuscript: Pal&#x000e1;cio MAG;
obtaining funding: Pal&#x000e1;cio MAG, Timerman A; critical revision of the manuscript for
intellectual content: Pal&#x000e1;cio MAG, Paiva EF, Azevedo LCP, Timerman A.</p></fn><fn fn-type="conflict"><p><bold>Potential Conflict of Interest</bold></p><p>No potential conflict of interest was reported.</p></fn><fn fn-type="other"><p><bold>Sources of Funding</bold></p><p>The study was partially funded by CAPES, Instituto Dante Pazzanese de Cardiologia,
Funda&#x000e7;&#x000e3;o Adib Jatene, and Hospital S&#x000ed;rio-Liban&#x000ea;s.</p></fn><fn fn-type="other"><p><bold>Study Association</bold></p><p>The study is part of doctoral thesis of Manoel Pal&#x000e1;cio, by Instituto Dante Pazzanese
de Cardiologia and University of S&#x000e3;o Paulo.</p></fn></fn-group><ack><title>Acknowledgements</title><p>To Andreza Conti Patara, for randomization safekeeping and confidential preparation of
treatment, and to Ernande Xavier dos Santos, Fl&#x000e1;vio Silva de Novais and Renato Serapi&#x000e3;o,
for the general assistance in animals preparation.</p></ack><ref-list><title>References</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Cooper</surname><given-names>JM</given-names></name></person-group><article-title>Cardiopulmonary resuscitation: history, current practice, and future
direction</article-title><source>Circulation</source><year>2006</year><volume>114</volume><issue>25</issue><fpage>2839</fpage><lpage>2849</lpage><pub-id pub-id-type="pmid">17179033</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000fc;nser</surname><given-names>MW</given-names></name><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Wenzel</surname><given-names>V</given-names></name></person-group><article-title>A century of arginine vasopressin research leading to new therapeutic
strategies</article-title><source>Anesthesiology</source><year>2006</year><volume>105</volume><issue>3</issue><fpage>444</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">16931974</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babbs</surname><given-names>CF</given-names></name><name><surname>Berg</surname><given-names>RA</given-names></name><name><surname>Kette</surname><given-names>F</given-names></name><name><surname>Kloeck</surname><given-names>WG</given-names></name><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Lurie</surname><given-names>KG</given-names></name><etal>et al</etal><collab>American Heart AssociationInternational Liaison Committee on
Resuscitation</collab></person-group><article-title>Use of pressures in the treatment of cardiac arrest</article-title><source>Ann Emerg Med</source><year>2001</year><volume>37</volume><issue>4 </issue><supplement> Suppl</supplement><fpage>S152</fpage><lpage>S162</lpage><pub-id pub-id-type="pmid">11290979</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname><given-names>KB</given-names></name><name><surname>Ewy</surname><given-names>GA</given-names></name><name><surname>Voorhees</surname><given-names>WD</given-names></name><name><surname>Babbs</surname><given-names>CF</given-names></name><name><surname>Tacker</surname><given-names>WA</given-names></name></person-group><article-title>Myocardial perfusion pressure: a predictor of 24-hour survival during
prolonged cardiac arrest in dogs</article-title><source>Resuscitation</source><year>1988</year><volume>16</volume><issue>4</issue><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">2849790</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradis</surname><given-names>NA</given-names></name><name><surname>Martin</surname><given-names>GB</given-names></name><name><surname>Rivers</surname><given-names>EP</given-names></name><name><surname>Goetting</surname><given-names>MG</given-names></name><name><surname>Appleton</surname><given-names>TJ</given-names></name><name><surname>Feingold</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Coronary perfusion pressure and the return of spontaneous circulation
in human cardiopulmonary resuscitation</article-title><source>JAMA</source><year>1990</year><volume>263</volume><issue>8</issue><fpage>1106</fpage><lpage>1113</lpage><pub-id pub-id-type="pmid">2386557</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>CG</given-names></name><name><surname>Werman</surname><given-names>HA</given-names></name><name><surname>Davis</surname><given-names>EA</given-names></name><name><surname>Hobson</surname><given-names>J</given-names></name><name><surname>Hamlin</surname><given-names>RL</given-names></name></person-group><article-title>The effects of graded doses of epinephrine on regional myocardial
blood flow during cardiopulmonary resuscitation in swine</article-title><source>Circulation</source><year>1987</year><volume>75</volume><issue>2</issue><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">3802451</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Brinkmann</surname><given-names>A</given-names></name><name><surname>Pfenninger</surname><given-names>EG</given-names></name><name><surname>Lurie</surname><given-names>KG</given-names></name><name><surname>Goertz</surname><given-names>A</given-names></name><name><surname>Lindner</surname><given-names>IM</given-names></name></person-group><article-title>Effect of vasopressin on hemodynamic variables, organ blood flow, and
acid-base status in a pig model of cardiopulmonary resuscitation</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><issue>3</issue><fpage>427</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">8368541</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Prengel</surname><given-names>AW</given-names></name><name><surname>Pfenninger</surname><given-names>EG</given-names></name><name><surname>Lindner</surname><given-names>IM</given-names></name><name><surname>Strohmenger</surname><given-names>HU</given-names></name><name><surname>Georgieff</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Vasopressin improves vital organ blood flow during closed-chest
cardiopulmonary resuscitation in pigs</article-title><source>Circulation</source><year>1995</year><volume>91</volume><issue>1</issue><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">7805205</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunde</surname><given-names>K</given-names></name><name><surname>Steen</surname><given-names>PA</given-names></name></person-group><article-title>The use of vasopressure agents during cardiopulmonary
resuscitation</article-title><source>Crit Care Clin</source><year>2012</year><volume>28</volume><issue>2</issue><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">22433482</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>AW</given-names></name><name><surname>May</surname><given-names>RE</given-names></name><name><surname>Mitch</surname><given-names>WE</given-names></name></person-group><article-title>Comparison of peptide and nonpeptide receptor-mediated responses in
rat tail artery</article-title><source>J Cardiovasc Pharmacol</source><year>1992</year><volume>20</volume><issue>2</issue><fpage>282</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">1381020</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>CL</given-names></name><name><surname>Landry</surname><given-names>DW</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name></person-group><article-title>Science review: vasopressin and the cardiovascular system part 1 -
receptor physiology</article-title><source>Crit Care</source><year>2003</year><volume>7</volume><issue>6</issue><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">14624682</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>CL</given-names></name><name><surname>Landry</surname><given-names>DW</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name></person-group><article-title>Science review: vasopressin and the cardiovascular system part 2 -
clinical physiology</article-title><source>Crit Care</source><year>2004</year><volume>8</volume><issue>1</issue><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">14975041</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumar</surname><given-names>RW</given-names></name><name><surname>Otto</surname><given-names>CW</given-names></name><name><surname>Link</surname><given-names>MS</given-names></name><name><surname>Kronick</surname><given-names>SL</given-names></name><name><surname>Shuster</surname><given-names>M</given-names></name><name><surname>Callaway</surname><given-names>CW</given-names></name><etal>et al</etal></person-group><article-title>Part 8: adult advanced cardiovascular life support: 2010 American
Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care</article-title><source>Circulation</source><year>2010</year><volume>122</volume><issue>18</issue><supplement>Suppl 3</supplement><fpage>S729</fpage><lpage>S767</lpage><comment>Erratum in Circulation. 2011;123(6):e236.</comment><pub-id pub-id-type="pmid">20956224</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>RA</given-names></name><name><surname>Otto</surname><given-names>CW</given-names></name><name><surname>Kern</surname><given-names>KB</given-names></name><name><surname>Sanders</surname><given-names>AB</given-names></name><name><surname>Hilwig</surname><given-names>RW</given-names></name><name><surname>Hansen</surname><given-names>KK</given-names></name><etal>et al</etal></person-group><article-title>High-dose epinephrine results in greater early mortality after
resuscitation from prolonged cardiac arrest in pigs: a prospective, randomized
study</article-title><source>Crit Care Med</source><year>1994</year><volume>22</volume><issue>2</issue><fpage>282</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">8306688</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>V</given-names></name><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Krismer</surname><given-names>AC</given-names></name><name><surname>Miller</surname><given-names>EA</given-names></name><name><surname>Voelckel</surname><given-names>WG</given-names></name><name><surname>Lingnau</surname><given-names>W</given-names></name></person-group><article-title>Repeated administration of vasopressin but not epinephrine maintains
coronary perfusion pressure after early and late administration during prolonged
cardiopulmonary resuscitation in pigs</article-title><source>Circulation</source><year>1999</year><volume>99</volume><issue>10</issue><fpage>1379</fpage><lpage>1384</lpage><pub-id pub-id-type="pmid">10077524</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayr</surname><given-names>VD</given-names></name><name><surname>Wenzel</surname><given-names>V</given-names></name><name><surname>Voelckel</surname><given-names>WG</given-names></name><name><surname>Krismer</surname><given-names>AC</given-names></name><name><surname>Mueller</surname><given-names>T</given-names></name><name><surname>Lurie</surname><given-names>KG</given-names></name><etal>et al</etal></person-group><article-title>Developing a vasopressor combination in a pig model of adult asphyxial
cardiac arrest</article-title><source>Circulation</source><year>2001</year><volume>104</volume><issue>14</issue><fpage>1651</fpage><lpage>1656</lpage><pub-id pub-id-type="pmid">11581144</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeung</surname><given-names>KW</given-names></name><name><surname>Ryu</surname><given-names>HH</given-names></name><name><surname>Song</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>BK</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Heo</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>Variable effects of high-dose adrenaline relative to standard-dose
adrenaline on resuscitation outcomes according to cardiac arrest
duration</article-title><source>Resuscitation</source><year>2011</year><volume>82</volume><issue>7</issue><fpage>932</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">21482013</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schratter</surname><given-names>A</given-names></name><name><surname>Holzer</surname><given-names>M</given-names></name><name><surname>Sterz</surname><given-names>F</given-names></name><name><surname>Janata</surname><given-names>A</given-names></name><name><surname>Sipos</surname><given-names>W</given-names></name><name><surname>Uray</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>New conventional long-term survival normovolemic cardiac arrest pig
model</article-title><source>Resuscitation</source><year>2011</year><volume>82</volume><issue>1</issue><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">20947240</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lathers</surname><given-names>CM</given-names></name><name><surname>Tumer</surname><given-names>N</given-names></name><name><surname>Schoffstall</surname><given-names>JM</given-names></name></person-group><article-title>Plasma catecholamines, pH and blood pressure during cardiac arrest in
pigs</article-title><source>Resuscitation</source><year>1989</year><volume>18</volume><fpage>59</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">2554447</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Haak</surname><given-names>T</given-names></name><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Bothner</surname><given-names>U</given-names></name><name><surname>Lurie</surname><given-names>KG</given-names></name></person-group><article-title>Release of endogenous vasopressures during and after cardiopulmonary
resuscitation</article-title><source>Heart</source><year>1996</year><volume>75</volume><issue>2</issue><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">8673752</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hearse</surname><given-names>DJ</given-names></name></person-group><article-title>The elusive coypu: the importance of collateral flow and the search
for an alternative to the dog</article-title><source>Cardiovasc Res</source><year>2000</year><volume>45</volume><fpage>215</fpage><lpage>219</lpage></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neurauter</surname><given-names>A</given-names></name><name><surname>Nysaether</surname><given-names>J</given-names></name><name><surname>Kramer-Johansen</surname><given-names>J</given-names></name><name><surname>Eilevstj&#x000f8;nn</surname><given-names>J</given-names></name><name><surname>Paal</surname><given-names>P</given-names></name><name><surname>Myklebust</surname><given-names>H</given-names></name><etal>et al</etal></person-group><article-title>Comparison of mechanical characteristics of the human and porcine
chest during cardiopulmonary resuscitation</article-title><source>Resuscitation</source><year>2009</year><volume>80</volume><issue>4</issue><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">19195761</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname><given-names>G</given-names></name><name><surname>Dingman</surname><given-names>JF</given-names></name></person-group><article-title>Distribution, blood transport, and degradation of antidiuretic hormone
in man</article-title><source>J Clin Invest</source><year>1976</year><volume>57</volume><issue>5</issue><fpage>1109</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">1262458</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treschan</surname><given-names>TA</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name></person-group><article-title>The vasopressin system: physiology and clinical
strategies</article-title><source>Anesthesiology</source><year>2006</year><volume>105</volume><issue>3</issue><fpage>599</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">16931995</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frishman</surname><given-names>WH</given-names></name><name><surname>Vahdat</surname><given-names>S</given-names></name><name><surname>Bhatta</surname><given-names>S</given-names></name></person-group><article-title>Innovative pharmacologic approaches to cardiopulmonary
resuscitation</article-title><source>J Clin Pharmacol</source><year>1998</year><volume>38</volume><issue>9</issue><fpage>765</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">9753203</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairns</surname><given-names>CB</given-names></name><name><surname>Niemann</surname><given-names>JT</given-names></name></person-group><article-title>Hemodynamic effects of repeated doses of epinephrine after prolonged
cardiac arrest and CPR: preliminary observations in an animal
model</article-title><source>Resuscitation</source><year>1998</year><volume>36</volume><issue>3</issue><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">9627069</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulligan</surname><given-names>KA</given-names></name><name><surname>McKnite</surname><given-names>SH</given-names></name><name><surname>Lindner</surname><given-names>KH</given-names></name><name><surname>Lindstrom</surname><given-names>PJ</given-names></name><name><surname>Detloff</surname><given-names>B</given-names></name><name><surname>Lurie</surname><given-names>KG</given-names></name></person-group><article-title>Synergistic effects of vasopressin plus epinephrine during
cardiopulmonary resuscitation</article-title><source>Resuscitation</source><year>1997</year><volume>35</volume><issue>3</issue><fpage>265</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">10203408</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>AB</given-names></name><name><surname>Kern</surname><given-names>KB</given-names></name><name><surname>Atlas</surname><given-names>M</given-names></name><name><surname>Bragg</surname><given-names>S</given-names></name><name><surname>Ewy</surname><given-names>GA</given-names></name></person-group><article-title>Importance of the duration of inadequate coronary perfusion pressure
on resuscitation from cardiac arrest</article-title><source>J Am Coll Cardiol</source><year>1985</year><volume>6</volume><issue>1</issue><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">4008767</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittenberger</surname><given-names>JC</given-names></name><name><surname>Menegazzi</surname><given-names>JJ</given-names></name><name><surname>Callaway</surname><given-names>CW</given-names></name></person-group><article-title>Association of delay to first intervention with return of spontaneous
circulation in a swine model of cardiac arrest</article-title><source>Resuscitation</source><year>2007</year><volume>73</volume><issue>1</issue><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">17223246</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>IG</given-names></name><name><surname>Finn</surname><given-names>JC</given-names></name><name><surname>Jelinek</surname><given-names>GA</given-names></name><name><surname>Oxer</surname><given-names>HF</given-names></name><name><surname>Thompson</surname><given-names>PL</given-names></name></person-group><article-title>Effect of adrenaline on survival in out-of-hospital cardiac arrest: a
randomised double-blind placebo-controlled trial</article-title><source>Resuscitation</source><year>2011</year><volume>82</volume><issue>9</issue><fpage>1138</fpage><lpage>1143</lpage><pub-id pub-id-type="pmid">21745533</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukoyama</surname><given-names>T</given-names></name><name><surname>Kinoshita</surname><given-names>K</given-names></name><name><surname>Nagao</surname><given-names>K</given-names></name><name><surname>Tanjoh</surname><given-names>K</given-names></name></person-group><article-title>Reduced effectiveness of vasopressin in repeated doses for patients
undergoing prolonged cardiopulmonary resuscitation</article-title><source>Resuscitation</source><year>2009</year><volume>80</volume><issue>7</issue><fpage>755</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">19446387</pub-id></element-citation></ref></ref-list></back></article>